Blog
RSS FeedPosted by Michael Wonder on 12 Jul 2016
Proposal to award sole supply of metoprolol tartrate injection in the community and DHB hospitals
12 July 2016 - PHARMAC is seeking feedback on a proposal for a sole supply arrangement for Mylan New Zealand Limited’s ...
Posted by Michael Wonder on 12 Jul 2016
Proposal to list new brands of zoledronic acid and vecuronium bromide
12 July 2016 - PHARMAC is seeking feedback on a provisional agreement with Mylan New Zealand Limited for the listing of ...
Posted by Michael Wonder on 07 Jul 2016
Proposal to award sole supply to goserelin acetate (Zoladex) and reference price leuprorelin acetate (Eligard and Lucrin PDS)
7 July 2016 - PHARMAC has entered into a provisional agreement with AstraZeneca. ...
Posted by Michael Wonder on 28 Jun 2016
Cancer patients get another option with PHARMAC eyeing funding for Keytruda
28 June 2016 - Melanoma patients are likely to get a second drug treatment option under a new proposal to provide ...
Posted by Michael Wonder on 28 Jun 2016
Proposal relating to pembrolizumab (Keytruda), nivolumab (Opdivo), posaconazole (Noxafil) and raltegravir (Isentress)
28 June 2016 - PHARMAC recently announced a decision to fund nivolumab (Opdivo) for patients with unresectable or metastatic (stage III ...
Posted by Michael Wonder on 28 Jun 2016
Proposal to list cholic acid (Cholebiol) for rare disorder
28 June 2016 - PHARMAC is seeking feedback on a proposal to list cholic acid (Cholebiol) resulting from a provisional agreement ...
Posted by Michael Wonder on 27 Jun 2016
Proposal for sole subsidised supply of progestogen-only long-acting intra-uterine system (Mirena)
27 June 2016 - Following a request for proposals for the supply of a long-acting intra-uterine progestagen, PHARMAC is seeking feedback ...
Posted by Michael Wonder on 24 Jun 2016
Enoxaparin sodium and plerixafor proposal
24 June 2016 - PHARMAC is seeking feedback on a proposal involving enoxaparin sodium and plerixafor, resulting from a provisional agreement ...
Posted by Michael Wonder on 10 Jun 2016
PHARMAC to seek further advice on azithromycin funding proposal
10 June 2016 - PHARMAC received a number of high-quality, well considered responses to the proposal to amend the funding restrictions ...
Posted by Michael Wonder on 02 Jun 2016
Proposal for the supply of influenza vaccine
2 June 2016 - Following a request for proposals for the supply of influenza vaccine, issued on 3 February 2016, PHARMAC ...
Posted by Michael Wonder on 30 May 2016
Proposals to widen funding access to important vaccines
30 May 2016 - PHARMAC is asking the public for feedback on proposals to widen funding access to the varicella (chickenpox) ...
Posted by Michael Wonder on 05 May 2016
Proposal to widen funded access to temozolomide for treatment of neuroendocrine tumours and high grade gliomas
4 May 2016 - As part of PHARMAC’s 2015/16 annual Invitation to Tender, PHARMAC is proposing to widen access to fully-funded ...
Posted by Michael Wonder on 05 May 2016
Proposal to widen access to rituximab to include children with nephrotic syndrome
4 May 2016 - PHARMAC is seeking feedback on a proposal to amend the funding restrictions for rituximab in DHB hospitals. ...
Posted by Michael Wonder on 04 May 2016
Proposals to list hepatitis C treatments
4 May 2016 - PHARMAC is seeking feedback on two proposals to list two new treatments for hepatitis C. ...
Posted by Michael Wonder on 04 May 2016
Proposal to list nivolumab (Opdivo) for advanced melanoma
4 May 2016 - New Zealand has a very high incidence of advanced melanoma (metastatic or unresectable Stage III and IV ...